Critically reviewing impact of regulatory actions, not just FDA's

Authors

  • Peter G. M. Mol

    1. Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    2. Dutch Medicines Evaluation Board, Utrecht, The Netherlands
    Search for more papers by this author

E-mail: p.g.m.mol@umcg.nl

No abstract is available for this article.

Ancillary